Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Lisa Brents

Concepts (165)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Naphthalenes
9
2015
127
1.900
Why?
Indoles
10
2015
291
1.790
Why?
Receptor, Cannabinoid, CB1
9
2015
126
1.510
Why?
Personality Disorders
2
2018
22
1.290
Why?
Cannabinoids
3
2013
102
0.970
Why?
Behavioral Research
1
2021
8
0.860
Why?
Neonatal Abstinence Syndrome
1
2021
15
0.850
Why?
Morphine
1
2021
100
0.820
Why?
Narcotics
1
2021
111
0.800
Why?
Adult Survivors of Child Abuse
1
2018
20
0.710
Why?
Personality
1
2018
32
0.710
Why?
Substance Withdrawal Syndrome
1
2019
177
0.690
Why?
Buprenorphine
1
2019
121
0.670
Why?
Fetus
1
2019
228
0.670
Why?
Prenatal Exposure Delayed Effects
1
2019
210
0.630
Why?
Endocannabinoids
1
2016
27
0.610
Why?
Cocaine-Related Disorders
2
2018
259
0.590
Why?
Receptors, Cannabinoid
2
2012
19
0.570
Why?
Opioid-Related Disorders
1
2019
334
0.560
Why?
Stress, Psychological
1
2015
287
0.470
Why?
Child Abuse
1
2015
172
0.470
Why?
Hemiterpenes
1
2011
10
0.450
Why?
Metabolic Detoxication, Phase I
1
2011
11
0.450
Why?
Stilbenes
1
2011
61
0.430
Why?
Plant Extracts
1
2013
205
0.420
Why?
Glucuronosyltransferase
2
2012
156
0.420
Why?
Behavior, Animal
1
2012
227
0.400
Why?
Pain
1
2013
386
0.390
Why?
Animals
15
2021
14792
0.390
Why?
Body Temperature
4
2015
85
0.380
Why?
Binding, Competitive
4
2013
134
0.380
Why?
Animals, Newborn
2
2021
400
0.360
Why?
Substance-Related Disorders
1
2013
629
0.330
Why?
Rats
3
2021
3593
0.310
Why?
Hydroxylation
4
2012
61
0.280
Why?
Hypothermia
2
2015
41
0.260
Why?
Receptor, Cannabinoid, CB2
3
2013
60
0.260
Why?
Mice
9
2015
6401
0.240
Why?
Pregnancy
2
2021
2430
0.240
Why?
Female
7
2021
28945
0.230
Why?
Motor Activity
2
2015
269
0.220
Why?
Rats, Long-Evans
1
2021
25
0.220
Why?
Automation
1
2021
23
0.210
Why?
Video Recording
1
2021
96
0.210
Why?
ROC Curve
1
2021
256
0.200
Why?
Movement
1
2021
107
0.200
Why?
Cricetinae
4
2013
211
0.200
Why?
Molecular Structure
4
2013
334
0.190
Why?
Software
1
2021
278
0.180
Why?
Sensitivity and Specificity
1
2021
973
0.170
Why?
Risk
1
2019
361
0.170
Why?
CHO Cells
3
2013
130
0.170
Why?
Ligands
3
2013
256
0.170
Why?
Menstrual Cycle
1
2016
10
0.160
Why?
Humans
14
2018
52937
0.160
Why?
Young Adult
2
2018
4306
0.150
Why?
Fertility
1
2016
37
0.150
Why?
Progesterone
1
2016
80
0.150
Why?
Pentacyclic Triterpenes
2
2012
7
0.150
Why?
Brain
3
2015
1466
0.150
Why?
Kinetics
3
2012
740
0.150
Why?
Receptors, Opioid, mu
2
2013
44
0.150
Why?
Protein Binding
3
2013
786
0.150
Why?
Drug Tolerance
1
2015
63
0.140
Why?
Personality Assessment
1
2015
20
0.140
Why?
Male
6
2018
28317
0.140
Why?
Mice, Inbred Strains
2
2012
211
0.140
Why?
Cytochrome P-450 Enzyme System
2
2012
196
0.130
Why?
Cannabis
1
2016
117
0.130
Why?
Chi-Square Distribution
1
2015
331
0.130
Why?
Cyclohexanols
1
2013
22
0.130
Why?
Membranes
1
2013
17
0.130
Why?
Psychiatric Status Rating Scales
1
2015
361
0.130
Why?
Mass Spectrometry
2
2012
324
0.130
Why?
Analysis of Variance
1
2015
675
0.120
Why?
Drug Synergism
1
2013
171
0.120
Why?
Recombinant Proteins
2
2012
595
0.120
Why?
Anticarcinogenic Agents
1
2012
47
0.120
Why?
Drug Interactions
1
2013
220
0.120
Why?
Conditioning, Operant
1
2013
109
0.120
Why?
Quinuclidines
1
2013
43
0.120
Why?
YY1 Transcription Factor
1
2012
8
0.120
Why?
Triterpenes
1
2012
14
0.120
Why?
Psychomotor Performance
1
2013
171
0.120
Why?
Drug Partial Agonism
1
2012
7
0.120
Why?
Drug Antagonism
1
2012
9
0.120
Why?
Pain Measurement
1
2013
260
0.120
Why?
Cannabinoid Receptor Agonists
1
2012
43
0.110
Why?
Prenylation
1
2011
3
0.110
Why?
Receptors, Adrenergic, beta-2
1
2012
24
0.110
Why?
Metabolic Detoxication, Phase II
1
2011
12
0.110
Why?
Isoproterenol
1
2012
65
0.110
Why?
Adrenergic beta-Agonists
1
2012
51
0.110
Why?
Receptor, erbB-2
1
2012
84
0.110
Why?
Piperidines
1
2012
103
0.110
Why?
GTP-Binding Proteins
1
2012
92
0.110
Why?
Predictive Value of Tests
1
2015
1063
0.110
Why?
Narcotic Antagonists
1
2012
123
0.110
Why?
Pyrazoles
1
2012
119
0.110
Why?
Biological Availability
1
2011
141
0.110
Why?
Antineoplastic Agents, Phytogenic
1
2012
90
0.110
Why?
Protein Transport
1
2012
207
0.110
Why?
Analgesics, Non-Narcotic
1
2012
148
0.110
Why?
Polymorphism, Genetic
1
2012
209
0.110
Why?
Repressor Proteins
1
2012
171
0.100
Why?
Middle Aged
2
2018
13660
0.100
Why?
Cell Membrane
1
2012
282
0.100
Why?
Plaque, Amyloid
1
2010
18
0.100
Why?
Chondroitin Sulfate Proteoglycans
1
2010
17
0.100
Why?
Extracellular Space
1
2010
48
0.100
Why?
Down-Regulation
1
2012
402
0.100
Why?
Lectins, C-Type
1
2010
34
0.100
Why?
Adult
2
2018
14365
0.100
Why?
Amyloid beta-Protein Precursor
1
2010
32
0.100
Why?
Models, Molecular
1
2011
433
0.100
Why?
Chromatography, High Pressure Liquid
1
2011
442
0.100
Why?
Dose-Response Relationship, Drug
1
2013
1572
0.090
Why?
Risk Factors
1
2018
4005
0.090
Why?
Cells, Cultured
1
2013
1840
0.090
Why?
Protein Processing, Post-Translational
1
2010
185
0.090
Why?
Nerve Tissue Proteins
1
2010
216
0.090
Why?
MicroRNAs
1
2012
366
0.090
Why?
Rats, Sprague-Dawley
1
2012
1809
0.080
Why?
Adolescent
1
2015
6883
0.060
Why?
Neoplasms
1
2012
1254
0.060
Why?
Breast Neoplasms
1
2012
1274
0.060
Why?
Injections, Intraperitoneal
1
2014
67
0.030
Why?
Administration, Inhalation
1
2014
120
0.030
Why?
Stereoisomerism
1
2013
135
0.030
Why?
Psychotropic Drugs
1
2013
83
0.030
Why?
Drug Inverse Agonism
1
2012
18
0.030
Why?
Sp Transcription Factors
1
2012
7
0.030
Why?
Cytochrome P-450 CYP1A2
1
2012
47
0.030
Why?
Pyrans
1
2012
27
0.030
Why?
Cricetulus
1
2012
102
0.030
Why?
Lysosomal-Associated Membrane Protein 1
1
2012
5
0.030
Why?
Aryl Hydrocarbon Hydroxylases
1
2012
79
0.030
Why?
Morpholines
1
2012
68
0.030
Why?
Glucuronides
1
2012
61
0.030
Why?
Cyclic AMP
1
2012
118
0.030
Why?
Mice, Nude
1
2012
278
0.030
Why?
rab GTP-Binding Proteins
1
2012
41
0.030
Why?
Protein Isoforms
1
2012
139
0.030
Why?
Microsomes, Liver
1
2012
214
0.030
Why?
HEK293 Cells
1
2012
254
0.030
Why?
Oxidation-Reduction
1
2012
395
0.030
Why?
Brevican
1
2010
8
0.030
Why?
Chondroitin Sulfates
1
2010
15
0.030
Why?
Culture Media
1
2010
103
0.020
Why?
Brain Chemistry
1
2010
83
0.020
Why?
Image Processing, Computer-Assisted
1
2010
281
0.020
Why?
Blotting, Western
1
2010
721
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
716
0.020
Why?
Neurons
1
2012
484
0.020
Why?
Mice, Transgenic
1
2010
729
0.020
Why?
Cell Line, Tumor
1
2012
1505
0.020
Why?
Cell Proliferation
1
2012
1128
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2012
895
0.020
Why?
Gene Expression Regulation
1
2013
1145
0.020
Why?
Analgesics, Opioid
1
2012
450
0.020
Why?
Immunohistochemistry
1
2010
1143
0.020
Why?
Cell Line
1
2010
1226
0.020
Why?
Alzheimer Disease
1
2010
326
0.020
Why?
Liver
1
2012
1263
0.020
Why?
Apoptosis
1
2012
1356
0.020
Why?
Brents's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description